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a  b  s  t  r  a  c  t
There  is  a growing  interest  among  mink  ranchers  to  select  their stock  for tolerance  to  the  Aleutian  mink
disease  virus  (AMDV).  Enzyme-linked  immunosorbent  assays  (ELISA)  are  used  to identify  mink  which
have  low anti-AMDV  antibody  titres  and  are  expected  to tolerate  the  AMDV  infection.  The  objective of
this  study  was  to calculate  the  accuracy  of  three  ELISA  systems  which  were  performed  on  blood  or  serum
of AMDV-inoculated  American  mink  (Neovison  vison)  at ﬁve  laboratories  in Canada,  USA,  Finland,  the
Netherlands  and  Denmark.  The  accuracy  was  determined  by comparing  the  ELISA  results  with  antibody
titres  measured  by  the  counter-immunoelectrophoresis  (CIEP)  using  10 two-fold  serial  dilutions  of  the
plasma.  Antibody  titres  of 880  black  mink  which  were  inoculated  with  a spleen  homogenate  from a  nat-
urally  infected  mink  were  measured  between  16  and  176  weeks  post-inoculation.  Each  ELISA  result  from
every  laboratory  covered  a wide  range  of  antibody  titres  and  the  Spearman’s  rank  correlation  coefﬁcients
between  CIEP  and ELISA  results  from  different  laboratories  varied  between  0.41 and 0.83, indicating  a
low  to  moderate  accuracy  of  ELISA  systems  for  ranking  mink  by antibody  titre.  The  recombinant  VP2-
based  ELISA  used  in  the  Netherlands  and  Finland  ranked  the mink  by  antibody  titres  more  accurately
than  did  the AMDV-G-based  ELISA  platforms  developed  in  Denmark  and  the USA,  suggesting  that  the
source  of  antigen  was one  of  the factors  affecting  the  accuracy  of  ELISA  results.  It  was  concluded  that  the
ELISA  systems,  particularly  those  based  on  AMDV-G  antigen,  require  further  reﬁnement  to  improve  their
accuracy  for  ranking  mink  by antibody  titre.
©  2016  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
Aleutian mink disease virus (AMDV, Carnivore amdoparvovirus
), a species of the genus Amdoparvovirus, family Parvoviridae
Cotmore et al., 2014), is present on mink ranches in almost
ll mink producing countries except Iceland (Gunnarsson, 2001).
he virus causes Aleutian disease, an immune-complex syn-
rome characterized by persistent antiviral antibody production,
ypergammaglobulinemia, plasmacytosis and progressive renal
isease in some mink (reviewed in Bloom et al., 1994), which
esults in economic losses through reduced reproductive per-
ormance and increased adult and kit mortality (Padgett et al.,
967; Alexandersen, 1986; Hansen and Lund, 1988; Broll and
lexandersen, 1996; Dyer et al., 2000). The disease has no cure
Abbreviations: AMDV, Aleutian mink disease virus; ELISA, enzyme-linked
mmunosorbent assays; CIEP, counter-immunoelectrophoresis; b, regression coef-
cient; R2, coefﬁcient of determination.
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E-mail address: ah.farid@dal.ca (A.H. Farid).
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166-0934/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
nor an effective vaccine (Porter et al., 1972; Aasted et al., 1998;
Castelruiz et al., 2005). Persistent testing of mink by counter-
immunoelectrophoresis (CIEP) and removal of seroconverted
animals has not been effective in permanent virus eradication from
many regions of the world, including Nova Scotia (Farid et al., 2012),
which is the largest mink-producing province in Canada.
It has been known for many years that some non-Aleutian mink
do not develop disease symptoms following exposure to AMDV
(reviewed in Bloom et al., 1994). There is evidence that tolerat-
ing AMDV infection has a genetic determinant (Henson et al., 1963;
Hadlow et al., 1984; Aasted and Hauch, 1988), indicating that toler-
ant populations could be established by genetic selection. An initial
attempt to establish a tolerant line of mink, however, did not result
in any improvement after one generation of selection (Larsen and
Porter, 1975), implying that the genetic control of tolerance does
not follow a simple Mendelian model of inheritance.
In recent years, there has been a growing interest among mink
ranchers in North America and Europe to select their stock for
increased tolerance to AMDV infection. Different ELISA systems
have recently been used to identify and keep animals with low
anti-AMDV antibody titres, based on the observation that antibody
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).







































mFig. 1. Sampling scheme and the number of min
itre is negatively associated with the severity of Aleutian disease
ymptoms (An and Ingram, 1977) and positively associated with
erum albumin: gamma globulin ratio (Andersson et al., 2015). The
vailable ELISA systems are either based on the recombinant VP2
Knuuttila et al., 2009) or the AMDV-G antigens which were devel-
ped independently in Denmark (Dam-Tuxen et al., 2014) and the
SA (Scientilla Development Company, LLC, Bath, Pennsylvania).
o date, the ELISA systems which were developed in Finland and
enmark have been optimized for the identiﬁcation of serocon-
erted animals in virus eradication programs (Knuuttila et al., 2009,
014; Andersson and Wallgren, 2013; Dam-Tuxen et al., 2014).
lthough accuracy of ELISA systems, deﬁned as the closeness of
greements between ELISA and CIEP results for ranking of mink by
ntibody titer, has not been fully investigated (Farid and Segervall,
014), they are being employed by some mink ranchers for select-
ng tolerant mink. The objective of this study was to measure
he accuracy of ranking mink by antibody titer using three avail-
ble ELISA systems at ﬁve laboratories in Finland, the Netherlands,
enmark, USA and Canada using the CIEP as the reference.
. Materials and methods
.1. The statement of animal care
All protocols were performed according to the standards of the
anadian Council on Animal Care after approval by the institu-
ional Animal Care and Use Committee. Animals were maintained in
n enclosed facility (Aleutian Disease Research Centre) according
o the standard industry practices in 61.0 × 30.5 × 20.3 cm cages.
rior to inoculation or blood sampling, animals were anesthetized
y intramuscular injection of ketamine hydrochloride (Ketalean,
imeda-MTC Cambridge, ON, Canada) and xylazine hydrochloride
Rompun 2%, Bayer Health Care) at the dose of 10 mg  and 2 mg
er kg live weight, respectively. Animals were anesthetized prior
o being euthanized by intracardiac injection of sodium pentobar-
ital (Euthanyl, Bimedia-MTC) at the dose of 100 mg  per kg body
eight or occasionally by CO2 exposure.
.2. Animal sampling
Black American mink (Neovison vison) were intranasally inocu-
ated once in September–December of 2010–2013 with 600 ID50 of
 spleen homogenate originated from one randomly selected mink
hich was naturally infected with AMDV (Farid et al., 2015). Ani-
als were of both sexes and were between six months and 1.5 yearsh were tested by ELISA at different laboratories.
of age at the time of inoculation. Animals were euthanized between
16 and 176 weeks post-inoculation in January, February or March
of 2011–2014. Blood was  collected from 880 mink by heart punc-
ture into heparinized tubes for plasma preparation for the CIEP test
and from 800 of these mink in plain tubes for serum preparation
(Fig. 1). Blood samples were kept in a refrigerator overnight and
centrifuged at 1397g (Porta Spin C826 centrifuge, Unico, Dayton,
NJ, USA) for 10 min  for serum and plasma preparation. Whole blood
was also collected in heparinized tubes by heart puncture in 2012
and 2013. Whole blood, serum and plasma samples were stored
at −80 ◦C until use. In addition, duplicate fresh blood was trans-
ferred from cut toe-nails of 254 mink onto two  absorbent combs in
January and February 2014 prior to euthanasia. Infectious materials
were stored and handled in a biosafety Level 2 laboratory following
approved Standard Operating Procedures.
2.3. Laboratory procedures
Undiluted and 10 two-fold serially diluted plasma samples
(1/1–1/1024) were tested by CIEP (Cho and Greenﬁeld, 1978) by an
experienced technician at the Animal Health Laboratory of the Nova
Scotia Department of Agriculture (Truro, Nova Scotia, Canada). The
antigen was the laboratory-adapted AMDV-G strain obtained from
the Research Foundation of the Danish Fur Breeders Association,
Glostrup, Denmark. Faint bands, which result from low antibody
titres, were recorded as doubtful. The titre of anti-AMDV antibod-
ies was  recorded as the reciprocal of the highest dilution of plasma
that showed positive or doubtful results.
Samples from the individuals whose antibody titres were deter-
mined by CIEP were tested by ELISA at ﬁve laboratories. Serum
samples from 800 mink were thawed and 55 L was  transferred to
each of two glass capillary tubes, shipped at ambient temperature
to the Fin Furlab, Vaasa, Finland, and to the Dutch Fur Breeders, CFE-
laboratorium, the Netherlands. These laboratories use the same
VP2-based ELISA system (Knuuttila et al., 2014) and read optical
densities at 450 nm (OD450). The Fin Furlab subtracts mean OD450
of two  blank wells from the results and the background-corrected
values are reported in eight classes (0–7) (Person. comm., P. Aro-
nen, 2015). The laboratory in the Netherlands does not correct OD
values for the background but adjusts them using a standard. The
adjusted values are reported in nine classes (0–8) with equal OD
values between classes, except class 8 which contained all read-
ings above a certain level (Person. comm., A. van de Louw, 2015).
Details of classiﬁcation methods at these laboratories are not pub-
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Table 1
Descriptive statistics of antibody titre measured by CIEP and ELISA at ﬁve laboratories and Spearman’s rank correlation coefﬁcients between CIEP and ELISA results (rs).
Measurement Antigen Sample source Number of samples Median Range rs
CIEP-doubtfula – Plasma 880 32.0 0–1024 –
CIEP-positivea – “ “ 16.0 0–1024 –
log2 (CIEP positive)a – “ “ 5.5 0−11 –
Netherlandsb VP2 Serum 800 2.0 0–8 0.831
Finlandb “ “ “ 1.0 0–7 0.809
Denmark AMDV-G Serum 442 68.3 0–116.6 0.629
“  “ Blood 557 66.0 0–103.5 0.468
USA  AMDV-G Blood 254 c 0.07–2.06 0.582

























antibody titres for selection purposes.
Although most of the samples from the same individuals were
F
na Reciprocals of highest plasma dilution which resulted in doubtful or positive CI
b Results from the Netherlands and Finland were classiﬁed into 8 and 7 groups, r
c Raw OD450 values with mean and standard deviation of 0.287 ± 0.418 (USA) and
icly available. The ELISA in the Netherlands is not used for detection
f infected animals and thus no cut-off point is calculated.
Filter paper slots on test cards which were supplied by Kopen-
agen Diagnostics, Glostrup, Denmark, were saturated with 25 L
f 442 serum and 557 whole blood samples, of which 131 were
aired samples, and were sent to Denmark for testing. The num-
er of paired serum samples tested in Denmark, Finland and the
etherlands was 386. Blood samples were tested because the Dan-
sh laboratory primarily test whole blood. Serum samples were
ested for comparing the results with those from other laboratories
nd to test concordance between blood and serum at this labora-
ory. ELISA was performed using the AMDV-G antigen, which is the
ame antigen used for the CIEP test in the current experiment, as
reviously described (Dam-Tuxen et al., 2014). Positive, negative
nd blank samples were used on each 384 well plate. The positive
ontrol was made up of a pool of AMDV positive sera, but its titre
as not been determined. The results were obtained in relative ﬂu-
rescence units (RFU) which range between 0 and 80,000, and were
ormalized in the Laboratory Information Management System to
he maximum of 100 using the equation 100*(RFU sample − RFU
lank)/(RFU positive standard – RFU blank). The results were also
eported as positive or negative samples, corresponding to over or
ig. 2. Joint distribution of antibody titre measured by CIEP and ELISA performed in Finla
umber of observations.2(CIEP) = 0 if CIEP = 0 and log2(CIEP) + 1 if CIEP > 0.
ively, by the laboratories.
2 ± 0.388 (Canada).
under the deﬁned cut-off value of 1.0. Samples with values under
1.0 were considered sero-negative (Person. Comm., L. Bruun, 2015).
Paired fresh blood from the 254 mink that were collected in
2014 onto two absorbent combs were tested at the two North
American laboratories in Canada and the USA. The animals were
those whose serum samples were tested at the three laboratories
in Europe (Fig. 1). Combs were air dried for one hour and kept in
a refrigerator before sending to the laboratories at ambient tem-
perature. These laboratories use an ELISA system developed by the
Scientilla Development Company, LLC, Bath, Pennsylvania, which
is based on the AMDV-G antigen. The OD450 values are read using
ELX800 (USA) or ELX808 (Canada) plate readers (BioTek, Winooshi,
VT, USA). These laboratories run negative controls on each plate
but the results are not adjusted for the background, which ranges
between 0.05 and 0.06 OD. Four positive controls with OD450 of
2.626–2.645 (average of 2.63) are run on each plate, but antibody
titres of these samples are not known. These laboratories do not aim
at identifying infected animals, rather their goal is to rank mink fortested in all laboratories (Fig. 1), some samples were not tested at
all laboratories because of insufﬁcient sample volume or the need
nd and the regression of ELISA on CIEP results. Bubble sizes are proportional to the











iig. 3. Joint distribution of antibody titre measured by CIEP and ELISA performed in 
o  the number of observations.
or fresh blood by the USA and Canadian laboratories. The Danish
aboratory tests blood, but serum samples were tested to compare
lood and serum at the same laboratory
.4. Data analysis
The relationships between CIEP and the ELISA results from dif-
erent laboratories (accuracy) were determined by Spearman’s rank
orrelation (rs) and linear and quadratic regression using SAS for
indows, Version 9.4. Graphs were also generated by SAS. CIEP val-
es were transformed to log2(CIEP) = 0 if CIEP = 0 and log2(CIEP) + 1
f CIEP > 0 prior to the analyses. Sensitivity of ELISA relative to CIEP
Fig. 4. Joint distribution of antibody titre measured by CIEP and ELISA petherlands and the regression of ELISA on CIEP results. Bubble sizes are proportional
was calculated by the Clinical Research Calculator of the VassarStats
(http://vassarstats.net/clin1.html).
3. Results
3.1. Descriptive statistics of the CIEP and ELISA results
Descriptive statistics of the CIEP and ELISA results are shown in
Table 1. Inclusion of doubtful CIEP results doubled the median of
antibody titre from 16 to 32. The number of samples with antibody
titre of 1024 based on positive and doubtful CIEP results was  four
and eight, respectively, and the number of seronegative samples
(CIEP = 0) based on positive and doubtful results was 39 and 30,
rformed in Denmark (serum) and the regression of ELISA on CIEP.













(Fig. 5. Joint distribution of antibody titre measured by CIEP and EL
espectively. Only the results of analyses based on positive CIEP are
eported because they were very close to those based on doubtful
IEP.
.2. Accuracy of ELISA systems
Each ELISA result from all ﬁve laboratories covered a wide range
f antibody titres, often up to 10 fold in difference (Figs. 2–7). Indi-
iduals with the titre of 1024 tended to have reduced ELISA values
ompared with those with 64–256 titres which showed the peaks of
LISA results in all laboratories, and the declines were particularly
oticeable for the USA and Canadian laboratories (Figs. 6 and 7).
he rs coefﬁcients showed moderate concordance between the
og2(CIEP) and ELISA results from the Netherlands and Finland
0.831 and 0.809), but the results from Denmark, the USA and
Fig. 6. Joint distribution of antibody titre measured by CIEP and Eerformed in Denmark (blood) and the regression of ELISA on CIEP.
Canada had weaker associations with antibody titres (0.426–0.629)
(Table 1). The regressions of ELISA results from the Netherlands,
Finland and Denmark on log2(CIEP) were quadratic, and those from
the USA and Canada were linear (Table 2). Deviations from linearity
were minor in all cases and increased the R2 values by less than 2%.
Both linear and quadratic regression coefﬁcients had positive signs
for samples tested in the Netherlands and Finland, and the power
regression equations of the ELISA results (Y) on log2(CIEP) (X)
were Y = 0.7417X1.5323 (R2 = 0.63) for Finland and Y = 1.8839X1.33673
(R2 = 0.66) for the Netherlands, showing 2% higher R2 values.3.3. Sensitivity of ELISA
Sensitivity of the ELISA tests performed in Denmark relative to
CIEP were 1.0 (95% CI 0.991–1.0, n = 557) for blood and 0.997 (95%
LISA performed in USA and the regression of ELISA on CIEP.
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Fig. 7. Joint distribution of antibody titre measured by CIEP and ELI
Table 2
Linear (b1) and quadratic (b2) regression coefﬁcients, their standard errors (SE)
and probability of signiﬁcance (P-values) of ELISA readings on log2(CIEP) a and the
coefﬁcient of determination (R2).
Laboratory b1 ± SE P-value b2 ± SE P-value R2
Netherlands 0.265 ± 0.049 <0.001 0.027 ± 0.005 <0.001 0.65
Finland 0.162 ± 0.058 0.005 0.041 ± 0.006 <0.001 0.61
Denmark (serum) 6.818 ± 1.063 <0.001 −0.245 ± 0.105 0.019 0.35
Denmark (blood) 9.922 ± 1.077 <0.001 −0.569 ± 0.099 <0.001 0.29
USA  0.064 ± 0.009 <0.001 0.14
























ma Reciprocal of the highest plasma dilution which resulted in positive CIEP and
ransformed to log2(CIEP) = 0 if CIEP = 0 and log2(CIEP) + 1 if CIEP >0.
I 0.984–0.999, n = 442) for serum. Sensitivity was  not computed
or the other laboratories because the cut-off points for the clas-
iﬁcation of infected and non-infected animals were not set (the
etherlands, USA and Canada) or animals were not classiﬁed based
n their infection status (Finland).
. Discussion
More than 30 years of persistent testing and removal of serocon-
erted mink, along with costly investments in biosecurity systems
nd depopulation-repopulation, have failed to permanently eradi-
ate AMDV from many ranches in Nova Scotia (Farid et al., 2012).
onsequently, some ranchers are considering an alternative strat-
gy of selecting mink for tolerance to AMDV infection. Recently
ome ranchers in North America and Europe began using different
LISA systems for the identiﬁcation of tolerant mink. The laborato-
ies in Finland and Denmark, which developed two of the ELISA
latforms, have not yet ofﬁcially recommended their methods
or anti-AMDV antibody quantiﬁcation, and limited information is
vailable on the accuracy of the ELISA system developed in Finland
Farid and Segervall, 2014). This is the ﬁrst study on the accuracy of
MDV-G antigen-based ELISA for ranking mink by antibody titre.
Mink that were used in this experiment were selected solelyn the basis of health and reproductive success, and were sampled
rom 16 to 176 weeks post-inoculation and ranged widely in age
from nine months to 3.5 years) at the time of sampling. These ani-
als thus resembled any mink herd which is under selection forSA performed in Canada and the regression of ELISA on CIEP.
tolerance to AMDV infection, and provided a unique resource for
investigating the accuracy of available ELISA platforms for ranking
mink by antibody titres.
Accuracy was  measured as the closeness of agreement between
the ELISA and the CIEP results for ranking mink for antibody titre.
CIEP was used as the standard because is the only commercially
available test for identiﬁcation of seroconverted mink in Canada
and has extensively been used for measuring antibody titres (Bloom
et al., 1975, 1982; An and Ingram, 1977; An et al., 1978; Aasted
and Cohn, 1982; Hadlow et al., 1983, 1984; Hahn and Hahn, 1983).
Measuring antibody titre by CIEP requires serial dilution of sam-
ples, which is too expensive for commercial mink ranchers, making
ELISA a more practical and affordable tool for this purpose. It is
necessary to demonstrate the accuracy of any ELISA platform for
ranking mink by antibody titre before recommending this tool to
mink ranchers.
The range of antibody titres was large (0–1024) and ELISA results
spanned the entire scale of values from Finland (0–7) and the
Netherlands (0–8), and the maximum adjusted RFU of serum and
blood samples at the Danish laboratory were higher than 100,
which is the value of the positive control (Table 1). Using frozen-
thawed samples could have possibly decreased the magnitudes of
antibody titres, but ranking order of the mink, and thus the results
of this study, were not affected compared with using fresh samples.
The maximum OD values of the samples tested in this experiment
were slightly smaller than 2.63, which was the OD  of the controls
at the laboratories in the USA and Canada.
The rs coefﬁcients and regression analyses were conﬁrmatory
because differences between correlation coefﬁcient and the R val-
ues of the regression analyses deviated by less than 0.07 within
each laboratory. The only exception was  the result from the USA
laboratory where the rs coefﬁcient (0.582) was larger than R (0.37).
Laboratories in Finland and the Netherlands generated the most
accurate results (Tables 1 and 2). The rs coefﬁcient of 0.801 between
CIEP and ELISA results from Finland was larger than 0.77 and 0.71 in
a previous report for two sets of samples tested at the same labora-
tory (Farid and Segervall, 2014). It can be concluded that although
the current ELISA systems are not perfect tools for ranking mink
by antibody titre, the laboratories in the Netherlands and Finland
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he other laboratories. The results imply that the source of anti-
en was possibly one of the factors affecting the accuracy of the
LISA platforms and that the recombinant VP2-based ELISA was
ore accurate than the AMDV-G based ELISA.
Differences in the shape of the regression lines, which were sim-
lar for the same ELISA platforms used at different laboratories,
eserve further attention. The relationship between antibody titre
nd OD is non-linear, yet there is no published information sug-
esting that the linear dynamic range of standard curves for these
LISA platforms has been established. At high antibody titres, the
LISA results tended to decrease in the current study, which were
articularly noticeable for the results from the USA and Canada
Figs. 2–7). Yet, deviation from linearity was not statistically sig-
iﬁcant for the laboratories in the USA and Canada because of the
mall number of observations. The tendency for declines in ELISA
esults at high antibody titres, which was more pronounced in the
MDV-G than the VP2-based platforms, was possibly caused by the
igh-dose hook effect (Tate and Ward, 2004) as well as a small num-
er of samples with high antibody titre. The results suggest that the
MDV-G based ELISA developed in the USA had a lower accuracy
han the other two platforms for the identiﬁcation of animals with
igh antibody titres, which is a rather serious drawback and needs
o be rectiﬁed.
The observation that each ELISA level at all the laboratories cov-
red a wide range of antibody titres (Figs. 2–7), and the presence
f large discrepancies between ELISA and CIEP results in ranking of
nimals with high antibody titres, suggest that some reﬁnements
re needed before recommending the available ELISA systems as
ools for ranking mink by antibody titres. Accurate results can only
e obtained when OD450 readings fall within the linear dynamic
ange of the standard curve of any ELISA platform. Samples with
eadings beyond the linear dynamic range of ELISA need to be
urther diluted to obtain more accurate estimates. Samples from
on-infected ranches in Finland and Denmark occasionally gener-
ted high OD450 values (Knuuttila et al., 2009; Dam-Tuxen et al.,
014) implying that ELISA results, for unknown reasons, may  not
e correct in a small fraction of samples. For this reason, testing
amples in duplicate or triplicate, preferably on different plates,
ould improve the accuracy of the results and may  be warranted
or elite breeder animals.
ELISA systems are used in Finland (Knuuttila et al., 2009, 2014),
weden (Andersson and Wallgren, 2013) and Denmark (Dam-
uxen et al., 2014) primarily for the identiﬁcation of sero-converted
ink in virus eradication programs, whereas the aim of laborato-
ies at the Netherlands, USA and Canada is to rank mink by antibody
itre. The merit of ELISA systems for ranking mink by antibody
itre is different from that used for detecting infected animals in
irus eradication programs where sensitivity and speciﬁcity are
aramount. Sensitivity of the results from Denmark, which was
he only laboratory that classiﬁed the samples into positive and
egative for infection, were high for both serum and blood and in
act higher than the estimates (0.7254–0.9935) previously reported
y this laboratory (Dam-Tuxen et al., 2014). In the current study,
here were 25 (5.1%) and 10 (1.8%) CIEP negative but ELISA positive
erum and blood samples, respectively, lower than the 10.92% of
374 blood samples tested in Denmark (Dam-Tuxen et al., 2014).
he number of samples that were positive on CIEP but negative on
LISA were one (0.22%) for serum and zero for blood, which were
lso smaller than 5.65% of 1374 blood samples tested in Denmark
Dam-Tuxen et al., 2014). The results suggested that both blood and
erum can be tested with the Danish system for the identiﬁcation
f sero-converted animals with a high sensitivity, and that freezing
hen thawing of plasma and blood samples and their shipment to
enmark at ambient temperature did not have any adverse effect
n the results.logical Methods 235 (2016) 144–151
5. Conclusion
The ELISA tests which are currently performed at ﬁve laborato-
ries in Canada, USA, Finland, the Netherlands and Denmark differ
in the accuracy with which they ranked mink by antibody titre.
The laboratories in Finland and the Netherlands, which are using a
recombinant VP2-based ELISA, ranked the mink by antibody titre
more accurately than did the other laboratories. The AMDV-G based
ELISA, which is being used in the USA and Canada, had the low-
est accuracy. Results from the laboratory in Denmark showed very
high sensitivity for the identiﬁcation of seroconverted mink, for
which this system was  designed, but were not very accurate for
ranking mink by antibody titre. It was  concluded that the ELISA sys-
tems, particularly those based on AMDV-G antigen, require further
reﬁnement to improve their accuracy for ranking mink by antibody
titre.
Competing interests
The authors declared that they have no competing interest.
Acknowledgments
We  would like to acknowledge Irshad Hussain and Irin Arju for
their assistance in mink sampling, and the staff of the Pathology
Laboratory, Nova Scotia Department of Agriculture for perform-
ing the CIEP tests. Thomas Dam-Tuxen (Technology Manager,
Kopenhagen Fur, Kopenhagen Diagnostics, Denmark), Leif Bruun
(Director R&D, Kopenhagen Fur, Denmark), Pirjo Aronen (Fin
FurLab, Finland), Ad van de Louw and Louise Boekhorst (CFE-
laboratorium, the Netherlands) and the operators of laboratories
in Canada and the USA are acknowledged for performing the ELISA
tests and providing valuable technical information. Financial sup-
port from mink industry organizations (Canada Mink Breeders
Association, Nova Scotia Mink Breeders Association, Fur Farmers
of Canada Marketing Association, American Legend Cooperatives,
North American Fur Auctions, American Mink Council, American
Mink Farmers Research Foundation, Fur Commission USA), Agricul-
ture and Agri-Food Canada through the CARD Councils of Ontario,
British Columbia and Nova Scotia (Agri-Futures NS), Atlantic Inno-
vation Fund of Atlantic Opportunity Agency, and the Research
Acceleration Program of the Nova Scotia Department of Agriculture
is gratefully acknowledged.
References
Aasted, B., Cohn, A., 1982. Inhibition of precipitation in counter current
electrophoresis. A sensitive method for detection of mink antibodies to
Aleutian disease virus. Acta Path. Microbiol. Immunol. Scand. C 90, 15–19.
Aasted, B., Hauch, H., 1988. Studies on the progression of Aleutian disease in mink.
Acta Vet. Scand. 29, 315–321.
Aasted, B., Alexandersen, S., Christensen, J., 1998. Vaccination with Aleutian mink
disease parvovirus (AMDV) capsid proteins enhances disease, while
vaccination with the major non-structural AMDV protein causes partial
protection from disease. Vaccine 16, 1158–1165.
Alexandersen, S., 1986. Acute intestinal pneumonia in mink kits: experimental
reproduction of the disease. Vet. Pathol. 23, 579–588.
An, S.H., Ingram, D.G., 1977. Detection of inapparent Aleutian disease virus
infection in mink. Am.  J. Vet. Res. 38, 1619–1624.
An, S.H., DePauli, F.J., Wright, P., Ingram, D.G., 1978. Characteristics of inapparent
Aleutian disease virus infection in mink. Res. Vet. Sci. 24, 200–204.
Andersson, A.-M., Wallgren, P., 2013. Evaluation of two enzyme-linked
immunosorbent assay for serodiagnosis of Aleutian mink disease virus
infection in mink. Acta Vet. Scand., 55:86 http://www.actavetscand.com/
content/55/1/86.
Andersson, A.-M., Reineck, H.B., Nyman, A.-K., Wallgren, P., 2015. Quantitative
detection of antibodies to Aleutian disease virus in dried blood spots as an
estimation of hypergammaglobulinemia in mink. Virol. Mycol. 4, 147, http://
dx.doi.org/10.4172/2161-0517.1000147.
Bloom, M.E., Race, R.E., Hadlow, W.J., Chesebro, B., 1975. Aleutian disease of mink:














Porter, D.D., Larsen, A.E., Porter, H.G., 1972. The pathogenesis of Aleutian disease ofA.H. Farid, P.P. Rupasinghe / Journal o
loom, M.E., Race, R.E., Wolﬁnbarger, J.B., 1982. Identiﬁcation of a nonvirion
protein of Aleutian disease virus: mink with Aleutian disease have antibody to
both virion and nonvirion proteins. J. Virol. 43, 608–616.
loom, M.E., Kanno, H., Mori, S., Wolﬁnbarger, J.B., 1994. Aleutian mink disease:
puzzles and paradigms. Infect. Agents Dis. 3, 279–301.
roll, S., Alexandersen, S., 1996. Investigation of the pathogenesis of transplacental
transmission of Aleutian mink disease parvovirus in experimentally infected
mink. J. Virol. 70, 1455–1466.
astelruiz, Y., Blixenkrone-Moller, M.,  Aasted, B., 2005. DNA vaccination with the
Aleutian mink disease virus ND1 gene confer partial protection against disease.
Vaccine 23, 1225–1231.
ho, H.J., Greenﬁeld, J., 1978. Eradication of Aleutian disease of mink by
eliminating positive counterimmunoelectrophoresis test reactors. J. Clin.
Microbiol. 7, 18–22.
otmore, S.F., Agbandje-McKenna, M.,  Chiorini, J.A., Mukha, D.V., Pintel, D.J., Qiu, J.,
Soderlund-Venermo, M.,  Tattersall, P., Tijssen, P., Gatherer, D., Davison, A.J.,
2014. The family Parvoviridae. Arch. Virol. 159, 1239–1247.
am-Tuxen, R., Dahl, J., Jensen, T.H., Dam-Tuxen, T., Struve, T., Bruun, L., 2014.
Diagnosing Aleutian mink disease infection by a new fully automated ELISA or
by  counter current immunoelectrophoresis: a comparison of sensitivity and
speciﬁcity. J. Virol. Method. 199, 53–60.
yer, N.W., Ching, B., Bloom, M.E., 2000. Nonsuppurative meningoencephalitis
associated with Aleutian mink disease parvovirus infection in ranch mink. J.
Vet.  Diagn. Invest. 12, 159–162.
arid, A.H., Segervall, J., 2014. A comparison between ELISA and CIEP for measuring
antibody titres against Aleutian mink disease virus. Virol. Mycol. 4147, http://
dx.doi.org/10.4172/2161-0517.1000137.
arid, A.H., Zillig, M.L., Finley, G.G., Smith, G.C., 2012. Prevalence of the Aleutian
mink disease virus infection in Nova Scotia, Canada. Prev. Vet. Med. 106,
332–338.
arid, A.H., Hussain, I., Arju, I., 2015. Detection of the Aleutian mink disease virus
DNA and anti-viral antibodies in mink 10 days post-inoculation. J. Vet. Diagn.
Invest. 27, http://dx.doi.org/10.1177/1040638715580982.ogical Methods 235 (2016) 144–151 151
Gunnarsson, E., 2001. Documenting freedom from disease and re-establishing a
free status after a breakdown Aleutian disease (plasmacytosis) in farmed mink
in  Iceland. Acta Vet. Scand. 42 (Suppl. 1), 87.
Hadlow, W.J., Race, R.E., Kennedy, R.C., 1983. Comparative pathogenicity of four
strains of Aleutian disease virus for pastel and sapphire mink. Infect. Immun.
41, 1016–1023.
Hadlow, W.J., Race, R.E., Kennedy, R.C., 1984. Royal pastel mink respond variously
to inoculation with Aleutian disease virus of low virulence. J. Virol. 50, 38–41.
Hahn, E.C., Hahn, P.S., 1983. Autoimmunity in Aleutian disease: contribution of
antiviral and anti-DNA antibody to hypergammaglobulinemia. Infect. Immun.
41,  494–500.
Hansen, M.,  Lund, E., 1988. Pregnancy rate and foetal mortality in Aleutian disease
virus infected mink. Acta Vet. Scand. 29, 271–272.
Henson, J.B., Gorham, J.R., Leader, R.W., 1963. The familial occurrence of
hypergammaglobulinemia in mink. Tex. Rep. Biol. Med. 21, 37–42.
Knuuttila, A., Aronen, P., Saarinen, A., Vapalahti, O., 2009. Development and
evaluation of an enzyme-linked immunosorbent assay based on recombinant
VP2 capsids for the detection of antibodies to Aleutian mink disease virus. Clin.
Vaccine Immunol. 16, 1360–1365.
Knuuttila, A., Aronen, P., Eerola, M.,  Gardner, I.A., Virtala, A.M., Vapalahti, O., 2014.
Validation of an automated ELISA system for detection of antibodies to
Aleutian mink disease virus using blood samples collected in ﬁlter paper strips.
Virol. J. 11, 141, http://dx.doi.org/10.1186/1743-422X-11-141.
Larsen, A.E., Porter, D.D., 1975. Pathogenesis of Aleutian disease of mink:
identiﬁcation of nonprogressive infections. Infect. Immun. 11, 92–94.
Padgett, G.A., Gorham, J.R., Henson, J.B., 1967. Epizootiologic studies of Aleutian
disease: I. Transplacental transmission of the virus. J. Infect. Dis. 117, 35–38.mink. II. Enhancement of tissue lesions following the administration of a killed
virus vaccine or passive antibody. J. Immunol. 109, 1–7.
Tate, J., Ward, G., 2004. Interference in immunoassay. Clin. Biochem. Rev. 25,
105–120.
